These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24009001)

  • 21. Clinical implementation of NIPT - technical and biological challenges.
    Brady P; Brison N; Van Den Bogaert K; de Ravel T; Peeters H; Van Esch H; Devriendt K; Legius E; Vermeesch JR
    Clin Genet; 2016 May; 89(5):523-30. PubMed ID: 25867715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing use of existing prenatal genetic tests: Screening and diagnostic testing for aneuploidy.
    Stoll K; Norton ME
    Semin Perinatol; 2018 Aug; 42(5):296-302. PubMed ID: 30209012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disorders.
    Shaw J; Scotchman E; Chandler N; Chitty LS
    Reproduction; 2020 Nov; 160(5):A1-A11. PubMed ID: 32130205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive prenatal diagnosis: progress and potential.
    Daley R; Hill M; Chitty LS
    Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F426-30. PubMed ID: 24786470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-free fetal nucleic acid testing: a review of the technology and its applications.
    Sayres LC; Cho MK
    Obstet Gynecol Surv; 2011 Jul; 66(7):431-42. PubMed ID: 21944155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive prenatal detection of aneuploidy.
    Robinson C; van den Boom D; Bombard AT
    Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.
    Grace MR; Hardisty E; Dotters-Katz SK; Vora NL; Kuller JA
    Obstet Gynecol Surv; 2016 Aug; 71(8):477-87. PubMed ID: 27526871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal screening for chromosome abnormalities.
    Chitty L
    Br Med Bull; 1998; 54(4):839-56. PubMed ID: 10367418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive prenatal diagnosis in 2020.
    Lo YM
    Prenat Diagn; 2010 Jul; 30(7):702-3. PubMed ID: 20572103
    [No Abstract]   [Full Text] [Related]  

  • 31. A new era in noninvasive prenatal testing.
    Morain S; Greene MF; Mello MM
    N Engl J Med; 2013 Aug; 369(6):499-501. PubMed ID: 23862975
    [No Abstract]   [Full Text] [Related]  

  • 32. How to choose a test for prenatal genetic diagnosis: a practical overview.
    Sparks TN; Dugoff L
    Am J Obstet Gynecol; 2023 Feb; 228(2):178-186. PubMed ID: 36029833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context.
    Allyse M; Sayres LC; King JS; Norton ME; Cho MK
    Hum Reprod; 2012 Nov; 27(11):3123-31. PubMed ID: 22863603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACMG statement on noninvasive prenatal screening for fetal aneuploidy.
    Gregg AR; Gross SJ; Best RG; Monaghan KG; Bajaj K; Skotko BG; Thompson BH; Watson MS
    Genet Med; 2013 May; 15(5):395-8. PubMed ID: 23558255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].
    Montagnana M; Lippi G; Guidi GC
    Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate and long-term applications of technology.
    Holzgreve W; Nippert I; Gänshirt-Ahlert D; Schloo R; Miny P
    Clin Obstet Gynecol; 1993 Sep; 36(3):476-84. PubMed ID: 8403599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in genetic prenatal diagnosis and screening.
    Hardisty EE; Vora NL
    Curr Opin Pediatr; 2014 Dec; 26(6):634-8. PubMed ID: 25211161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.